Qatar Cardiometabolic Registry

Summary

Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) are closely related. T2DM risk equivalent for CVD and it remains the major cause of death in T2DM. Thus, patients with T2DM and CVD disease are at very high-risk of CVD-related mortality. Therefore, more aggressive metabolic and hemodynamic control is required in such patients to improve the prognosis. We recently initiated a cardio-metabolic clinical service at the Heart Hospital, where T2DM patients with existing CVD are simultaneously examined by Cardiologist and Diabetologist for optimal metabolic and hemodynamic control. We would like to start a clinical registry for all patients who attend this clinical service to collect import clinical data about this population. This registry will serve an important source for future clinical research in the field.

Eligibility

Inclusion Criteria:

* Patients with type 2 diabetes mellitus
* Newly diagnosed heart disease, such as ischemic heart disease, heart failure.

Exclusion Criteria:

* Patients who do not have type 2 diabetes mellitus
* Preexisting heart disease

Conditions3

Browse More Trials